Primary sclerosing cholangitis, chronic ulcerative colitis, and bile duct dysplasia—Case presentation
K.V. Narayanan Menon – 18 October 2006
A difficult case of primary sclerosing cholangitis
Hugo E. Vargas – 18 October 2006 – Key Concepts: 1The immediate postoperative concerns in a patient with primary sclerosing cholangitis.2Recognize the difficulties in assessing biliary health in patients that have had complicated postoperative biliary concerns.3Recognize the difficulty in ascertaining the presence of chronic rejection vs. recurrent primary sclerosing cholangitis. Liver Transpl. 12:S65–S67. 2006. © 2006 AASLD.
Recurrent primary sclerosing cholangitis: Clinical diagnosis and long‐term management issues
Fredric Gordon – 18 October 2006 – Key Concepts: 1Primary sclerosing cholangitis (PSC) in the nontransplant setting is a chronic, progressive liver disease characterized by diffuse stricturing of the biliary tree, cholestatic liver enzymes, and a compatible liver biopsy.2Cholangiography reveals irregularity of the bile duct wall, strictures, beading, and diverticula.3The typical biopsy reveals inflammation and fibrosis of the interlobular and septal bile ducts, often with obliteration or biliary‐type cirrhosis.4The precise pathogenetic mechanism remains elusive but is assumed to be an autoi
Budd‐Chiari syndrome: Radiologic findings
Patrick S. Kamath – 18 October 2006 – Key Concepts: 1Diagnosis of Budd‐Chiari syndrome can be made on the basis of radiological imaging alone without the need for liver biopsy.2Ultrasonography, computed tomography, and magnetic resonance imaging all show various degrees of occlusion of the hepatic veins and/or inferior vena cava. Hypertrophy of the caudate lobe may also be seen.3Computed tomographic and magnetic resonance imaging give a better idea of hepatic perfusion.
Acute rejection in HCV‐infected liver transplant recipients: The great conundrum
James R. Burton, Hugo R.
Transplantation for hepatocellular carcinoma: The Milan criteria and beyond
Richard B. Freeman – 18 October 2006 – Key Concepts: 1Liver transplantation offers excellent results for selected candidates with hepatocellular carcinoma (HCC).2Selection strategies have evolved but are mainly based on size and number of tumors, which are surrogates for vascular invasion.
Recurrence of autoimmune liver disease after liver transplantation: A systematic review
Manjushree Gautam, Rekha Cheruvattath, Vijayan Balan – 9 October 2006 – Recurrence of autoimmune liver disease in allografts has long been a topic of debate. We conducted a systematic review of the literature to examine the reported incidence of recurrence after liver transplantation of primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), and autoimmune hepatitis (AIH). The MEDLINE, EMBASE, and Cochrane electronic databases were used to identify articles.
Estimation of glomerular filtration rates after orthotopic liver transplantation: Evaluation of cystatin C–based equations
Thomas Gerhardt, Uwe Pöge, Birgit Stoffel‐Wagner, Manuela Ahrendt, Martin Wolff, Ulrich Spengler, Holger Palmedo, Tilman Sauerbruch, Rainer P. Woitas – 9 October 2006 – Early detection of renal dysfunction in patients after orthotopic liver transplantation is important. Creatinine‐based equations to estimate glomerular filtration rate (GFR) were found to be less accurate in liver transplant recipients than in their original populations.